BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37583846)

  • 21. Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China.
    Huang L; Zou J; Zhang Y; Gu J; Wu J; Zhang C
    BMJ Open; 2024 Mar; 14(3):e075138. PubMed ID: 38490657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.
    Shi L; Zheng Y; Cheng Z; Ji N; Niu C; Wang Y; Huang T; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
    Stem Cell Res Ther; 2022 Jul; 13(1):321. PubMed ID: 35842684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
    Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
    Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II-IV steroid-refractory acute graft-versus-host disease: a study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial.
    Yang D; Hou X; Qian K; Li Y; Hu L; Li L; Han M; Yao C; Liu D
    Trials; 2023 May; 24(1):306. PubMed ID: 37138332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury.
    Sun L; Wang F; Chen H; Liu D; Qu T; Li X; Xu D; Liu F; Yin Z; Chen Y
    Cell Transplant; 2019 Jul; 28(7):893-906. PubMed ID: 31012325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramyocardial Transplantation of Umbilical Cord Mesenchymal Stromal Cells in Chronic Ischemic Cardiomyopathy: A Controlled, Randomized Clinical Trial (HUC-HEART Trial).
    Ulus AT; Mungan C; Kurtoglu M; Celikkan FT; Akyol M; Sucu M; Toru M; Gul SS; Cinar O; Can A
    Int J Stem Cells; 2020 Nov; 13(3):364-376. PubMed ID: 32840230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis.
    Deng D; Zhang P; Guo Y; Lim TO
    Ann Rheum Dis; 2017 Aug; 76(8):1436-1439. PubMed ID: 28478399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial.
    Wang L; Zhang Z; Xu R; Wang X; Shu Z; Chen X; Wang S; Liu J; Li Y; Wang L; Zhang M; Yang W; Wang Y; Huang H; Tu B; Liang Z; Li L; Li J; Hou Y; Shi M; Wang FS
    Signal Transduct Target Ther; 2021 Jun; 6(1):217. PubMed ID: 34103473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular Vesicles Released from Neprilysin Gene-Modified Human Umbilical Cord-Derived Mesenchymal Stem Cell Enhance Therapeutic Effects in an Alzheimer's Disease Animal Model.
    Jeong H; Kim OJ; Oh SH; Lee S; Reum Lee HA; Lee KO; Lee BY; Kim NK
    Stem Cells Int; 2021; 2021():5548630. PubMed ID: 34899919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Curative Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells and Their Small Extracellular Vesicles in Treating Osteoarthritis.
    Tang S; Chen P; Zhang H; Weng H; Fang Z; Chen C; Peng G; Gao H; Hu K; Chen J; Chen L; Chen X
    Int J Nanomedicine; 2021; 16():8185-8202. PubMed ID: 34938076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice.
    Yin Y; Hao H; Cheng Y; Zang L; Liu J; Gao J; Xue J; Xie Z; Zhang Q; Han W; Mu Y
    Cell Death Dis; 2018 Jul; 9(7):760. PubMed ID: 29988034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
    Xie Q; Liu R; Jiang J; Peng J; Yang C; Zhang W; Wang S; Song J
    Stem Cell Res Ther; 2020 Dec; 11(1):519. PubMed ID: 33261658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Umbilical cord-derived mesenchymal stem cell sheets transplanted subcutaneously enhance cell retention and survival more than dissociated stem cell injections.
    Nakao M; Matsui M; Kim K; Nishiyama N; Grainger DW; Okano T; Kanazawa H; Nagase K
    Stem Cell Res Ther; 2023 Dec; 14(1):352. PubMed ID: 38072920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hUC-MSC-mediated recovery of subacute spinal cord injury through enhancing the pivotal subunits β3 and γ2 of the GABA
    Cao T; Chen H; Huang W; Xu S; Liu P; Zou W; Pang M; Xu Y; Bai X; Liu B; Rong L; Cui ZK; Li M
    Theranostics; 2022; 12(7):3057-3078. PubMed ID: 35547766
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
    Shu L; Niu C; Li R; Huang T; Wang Y; Huang M; Ji N; Zheng Y; Chen X; Shi L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
    Stem Cell Res Ther; 2020 Aug; 11(1):361. PubMed ID: 32811531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of Emphysema Severity by Human Umbilical Cord-Derived Mesenchymal Stem Cells in Mice.
    Laiman V; Lee YL; Hou YW; Fang YT; Chen YY; Lo YC; Heriyanto DS; Lan SC; Chen CL; Chen XY; Lee KY; Chang JH; Chuang HC
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Safety and Efficacy of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Patients With Heart Failure and Myocardial Infarction: A Meta-Analysis of Clinical Trials.
    Abouzid MR; Ali K; Kamel I; Esteghamati S; Saleh A; Ghanim M
    Cureus; 2023 Nov; 15(11):e49645. PubMed ID: 38033439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat-dose toxicity study of human umbilical cord mesenchymal stem cells in cynomolgus monkeys by intravenous and subcutaneous injection.
    Pan W; Gu L; Yang H; Xu C; Yang Z; Lu Q; Shi Y; Zhang L; Shao J; Chen Y; Pan X; Wu F; Pan R; Liang J; Zhang L
    Front Cell Dev Biol; 2023; 11():1273723. PubMed ID: 38020919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.